Obalon Therapeutics, Inc.
NASDAQ: OBLN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kelly Huang
- Employees
- 2
- Headquarters
- Carlsbad, United States
- IPO year
- 2016
- Market cap
- $5.5M
- Website
- http://www.obalon.com
Loading OBLN…
Loading profile data…Frequently asked questions about OBLN
What does Obalon Therapeutics, Inc. (OBLN) do?
Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients. This comprehensiv...
Where does OBLN trade?
Obalon Therapeutics, Inc. (OBLN) trades on the NASDAQ Global Market.
What sector is OBLN in?
Obalon Therapeutics, Inc. (OBLN) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Obalon Therapeutics, Inc.?
Kelly Huang is the chief executive officer of Obalon Therapeutics, Inc. (OBLN).
Where is Obalon Therapeutics, Inc. headquartered?
Obalon Therapeutics, Inc. is headquartered in United States.
Does OBLN pay a dividend?
Obalon Therapeutics, Inc. (OBLN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OBLN go public?
Obalon Therapeutics, Inc. (OBLN) completed its initial public offering in 2016.